Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Lisdexamfetamine in Adults With Attention Deficit Hyperactivity Disorder (ADHD) and Sluggish Cognitive Tempo (SCT)

NCT02635035 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT02635035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02635035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Lisdexamfetamine in Adults With Attention Deficit Hyperactivity Disorder (ADHD) and Sluggish Cognitive Tempo (SCT)
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2015
Completion date
January 9, 2019
Enrollment
38 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit disorder, attention deficit hyperactivity disorder